SODIUM ZIRCONIUM CYCLOSILICATE
Approved April 2019 for treatment or prevention of non-life-threatening hyperkalemia in CKD and/or HTN with proteinuria requiring treatment with angiotensin-aldosterone blocking agents.
Approved April 2019 for treatment or prevention of non-life-threatening hyperkalemia in CKD and/or HTN with proteinuria requiring treatment with angiotensin-aldosterone blocking agents.